Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: May, 2018 | Pages:
129 | Publisher: QYResearch
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
This report studies the global Cancer Gene Therapy market status and forecast, categorizes the global Cancer Gene Therapy market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.
In 2017, the global Cancer Gene Therapy market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx.x % between 2018 and 2025.
The major manufacturers covered in this report
Adaptimmune
GlaxoSmithKline
Bluebird bio
Merck
Celgene
Shanghai Sunway Biotech
BioCancell
Shenzhen SiBiono GeneTech
SynerGene Therapeutics
OncoGenex Pharmaceuticals
Genelux Corporation
Cell Genesys
Advantagene
GenVec
BioCancell
Celgene
Epeius Biotechnologies
Introgen Therapeutics
Ziopharm Oncology
Shenzhen SiBiono GeneTech
Altor Bioscience
Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
North America
Europe
Asia-Pacific
South America
Middle East & Africa
The regional scope of the study is as follows:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Gene Induced Immunotherapy
Oncolytic Virotherapy
Gene Transfer
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
Hospitals
Diagnostics Centers
Research Institutes
The study objectives of this report are:
To analyze and study the global Cancer Gene Therapy sales, value, status (2013-2017) and forecast (2018-2025).
Focuses on the key Cancer Gene Therapy manufacturers, to study the sales, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Cancer Gene Therapy are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders
Cancer Gene Therapy Manufacturers
Cancer Gene Therapy Distributors/Traders/Wholesalers
Cancer Gene Therapy Subcomponent Manufacturers
Industry Association
Downstream Vendors
Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Cancer Gene Therapy market, by end-use.
Detailed analysis and profiles of additional market players.
Table of Contents
Global Cancer Gene Therapy Market Research Report 2018
1 Cancer Gene Therapy Market Overview
1.1 Product Overview and Scope of Cancer Gene Therapy
1.2 Cancer Gene Therapy Segment by Type (Product Category)
1.2.1 Global Cancer Gene Therapy Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
1.2.2 Global Cancer Gene Therapy Production Market Share by Type (Product Category) in 2017
1.2.3 Gene Induced Immunotherapy
1.2.4 Oncolytic Virotherapy
1.2.5 Gene Transfer
1.3 Global Cancer Gene Therapy Segment by Application
1.3.1 Cancer Gene Therapy Consumption (Sales) Comparison by Application (2013-2025)
1.3.2 Hospitals
1.3.3 Diagnostics Centers
1.3.4 Research Institutes
1.4 Global Cancer Gene Therapy Market by Region (2013-2025)
1.4.1 Global Cancer Gene Therapy Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
1.4.2 North America Status and Prospect (2013-2025)
1.4.3 Europe Status and Prospect (2013-2025)
1.4.4 Asia-Pacific Status and Prospect (2013-2025)
1.4.5 South America Status and Prospect (2013-2025)
1.4.6 Middle East & Africa Status and Prospect (2013-2025)
1.5 Global Market Size (Value) of Cancer Gene Therapy (2013-2025)
1.5.1 Global Cancer Gene Therapy Revenue Status and Outlook (2013-2025)
1.5.2 Global Cancer Gene Therapy Capacity, Production Status and Outlook (2013-2025)
2 Global Cancer Gene Therapy Market Competition by Manufacturers
2.1 Global Cancer Gene Therapy Capacity, Production and Share by Manufacturers (2013-2018)
2.1.1 Global Cancer Gene Therapy Capacity and Share by Manufacturers (2013-2018)
2.1.2 Global Cancer Gene Therapy Production and Share by Manufacturers (2013-2018)
2.2 Global Cancer Gene Therapy Revenue and Share by Manufacturers (2013-2018)
2.3 Global Cancer Gene Therapy Average Price by Manufacturers (2013-2018)
2.4 Manufacturers Cancer Gene Therapy Manufacturing Base Distribution, Sales Area and Product Type
2.5 Cancer Gene Therapy Market Competitive Situation and Trends
2.5.1 Cancer Gene Therapy Market Concentration Rate
2.5.2 Cancer Gene Therapy Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Cancer Gene Therapy Capacity, Production, Revenue (Value) by Region (2013-2018)
3.1 Global Cancer Gene Therapy Capacity and Market Share by Region (2013-2018)
3.2 Global Cancer Gene Therapy Production and Market Share by Region (2013-2018)
3.3 Global Cancer Gene Therapy Revenue (Value) and Market Share by Region (2013-2018)
3.4 Global Cancer Gene Therapy Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.5 North America Cancer Gene Therapy Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.6 Europe Cancer Gene Therapy Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.7 Asia-Pacific Cancer Gene Therapy Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.8 South America Cancer Gene Therapy Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.9 Middle East & Africa Cancer Gene Therapy Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
4 Global Cancer Gene Therapy Supply (Production), Consumption, Export, Import by Region (2013-2018)
4.1 Global Cancer Gene Therapy Consumption by Region (2013-2018)
4.2 North America Cancer Gene Therapy Production, Consumption, Export, Import (2013-2018)
4.3 Europe Cancer Gene Therapy Production, Consumption, Export, Import (2013-2018)
4.4 Asia-Pacific Cancer Gene Therapy Production, Consumption, Export, Import (2013-2018)
4.5 South America Cancer Gene Therapy Production, Consumption, Export, Import (2013-2018)
4.6 Middle East & Africa Cancer Gene Therapy Production, Consumption, Export, Import (2013-2018)
5 Global Cancer Gene Therapy Production, Revenue (Value), Price Trend by Type
5.1 Global Cancer Gene Therapy Production and Market Share by Type (2013-2018)
5.2 Global Cancer Gene Therapy Revenue and Market Share by Type (2013-2018)
5.3 Global Cancer Gene Therapy Price by Type (2013-2018)
5.4 Global Cancer Gene Therapy Production Growth by Type (2013-2018)
6 Global Cancer Gene Therapy Market Analysis by Application
6.1 Global Cancer Gene Therapy Consumption and Market Share by Application (2013-2018)
6.2 Global Cancer Gene Therapy Consumption Growth Rate by Application (2013-2018)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries
7 Global Cancer Gene Therapy Manufacturers Profiles/Analysis
7.1 Adaptimmune
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Cancer Gene Therapy Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Adaptimmune Cancer Gene Therapy Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.1.4 Main Business/Business Overview
7.2 GlaxoSmithKline
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Cancer Gene Therapy Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 GlaxoSmithKline Cancer Gene Therapy Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.2.4 Main Business/Business Overview
7.3 Bluebird bio
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Cancer Gene Therapy Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Bluebird bio Cancer Gene Therapy Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.3.4 Main Business/Business Overview
7.4 Merck
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Cancer Gene Therapy Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Merck Cancer Gene Therapy Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.4.4 Main Business/Business Overview
7.5 Celgene
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Cancer Gene Therapy Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Celgene Cancer Gene Therapy Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.5.4 Main Business/Business Overview
7.6 Shanghai Sunway Biotech
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Cancer Gene Therapy Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 Shanghai Sunway Biotech Cancer Gene Therapy Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.6.4 Main Business/Business Overview
7.7 BioCancell
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Cancer Gene Therapy Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 BioCancell Cancer Gene Therapy Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.7.4 Main Business/Business Overview
7.8 Shenzhen SiBiono GeneTech
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Cancer Gene Therapy Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 Shenzhen SiBiono GeneTech Cancer Gene Therapy Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.8.4 Main Business/Business Overview
7.9 SynerGene Therapeutics
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.9.2 Cancer Gene Therapy Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 SynerGene Therapeutics Cancer Gene Therapy Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.9.4 Main Business/Business Overview
7.10 OncoGenex Pharmaceuticals
7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.10.2 Cancer Gene Therapy Product Category, Application and Specification
7.10.2.1 Product A
7.10.2.2 Product B
7.10.3 OncoGenex Pharmaceuticals Cancer Gene Therapy Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.10.4 Main Business/Business Overview
7.11 Genelux Corporation
7.12 Cell Genesys
7.13 Advantagene
7.14 GenVec
7.15 BioCancell
7.16 Celgene
7.17 Epeius Biotechnologies
7.18 Introgen Therapeutics
7.19 Ziopharm Oncology
7.20 Shenzhen SiBiono GeneTech
7.21 Altor Bioscience
8 Cancer Gene Therapy Manufacturing Cost Analysis
8.1 Cancer Gene Therapy Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Cancer Gene Therapy
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Cancer Gene Therapy Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Cancer Gene Therapy Major Manufacturers in 2017
9.4 Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
12 Global Cancer Gene Therapy Market Forecast (2018-2025)
12.1 Global Cancer Gene Therapy Capacity, Production, Revenue Forecast (2018-2025)
12.1.1 Global Cancer Gene Therapy Capacity, Production and Growth Rate Forecast (2018-2025)
12.1.2 Global Cancer Gene Therapy Revenue and Growth Rate Forecast (2018-2025)
12.1.3 Global Cancer Gene Therapy Price and Trend Forecast (2018-2025)
12.2 Global Cancer Gene Therapy Production, Consumption , Import and Export Forecast by Region (2018-2025)
12.2.1 North America Cancer Gene Therapy Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.2 Europe Cancer Gene Therapy Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.3 Asia-Pacific Cancer Gene Therapy Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.4 South America Cancer Gene Therapy Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.5 Middle East & Africa Cancer Gene Therapy Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.3 Global Cancer Gene Therapy Production, Revenue and Price Forecast by Type (2018-2025)
12.4 Global Cancer Gene Therapy Consumption Forecast by Application (2018-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer
List of Tables and Figures
Figure Picture of Cancer Gene Therapy
Figure Global Cancer Gene Therapy Production (Units) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Cancer Gene Therapy Production Market Share by Types (Product Category) in 2017
Figure Product Picture of Gene Induced Immunotherapy
Table Major Manufacturers of Gene Induced Immunotherapy
Figure Product Picture of Oncolytic Virotherapy
Table Major Manufacturers of Oncolytic Virotherapy
Figure Product Picture of Gene Transfer
Table Major Manufacturers of Gene Transfer
Figure Global Cancer Gene Therapy Consumption (Units) by Applications (2013-2025)
Figure Global Cancer Gene Therapy Consumption Market Share by Applications in 2017
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Diagnostics Centers Examples
Table Key Downstream Customer in Diagnostics Centers
Figure Research Institutes Examples
Table Key Downstream Customer in Research Institutes
Figure Global Cancer Gene Therapy Market Size (Million USD), Comparison (Units) and CAGR (%) by Regions (2013-2025)
Figure North America Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2013-2025)
Figure Asia-Pacific Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2013-2025)
Figure South America Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2013-2025)
Figure Middle East & Africa Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Cancer Gene Therapy Revenue (Million USD) Status and Outlook (2013-2025)
Figure Global Cancer Gene Therapy Capacity, Production (Units) Status and Outlook (2013-2025)
Figure Global Cancer Gene Therapy Major Players Product Capacity (Units) (2013-2018)
Table Global Cancer Gene Therapy Capacity (Units) of Key Manufacturers (2013-2018)
Table Global Cancer Gene Therapy Capacity Market Share of Key Manufacturers (2013-2018)
Figure Global Cancer Gene Therapy Capacity (Units) of Key Manufacturers in 2017
Figure Global Cancer Gene Therapy Capacity (Units) of Key Manufacturers in 2018
Figure Global Cancer Gene Therapy Major Players Product Production (Units) (2013-2018)
Table Global Cancer Gene Therapy Production (Units) of Key Manufacturers (2013-2018)
Table Global Cancer Gene Therapy Production Share by Manufacturers (2013-2018)
Figure 2017 Cancer Gene Therapy Production Share by Manufacturers
Figure 2017 Cancer Gene Therapy Production Share by Manufacturers
Figure Global Cancer Gene Therapy Major Players Product Revenue (Million USD) (2013-2018)
Table Global Cancer Gene Therapy Revenue (Million USD) by Manufacturers (2013-2018)
Table Global Cancer Gene Therapy Revenue Share by Manufacturers (2013-2018)
Table 2017 Global Cancer Gene Therapy Revenue Share by Manufacturers
Table 2018 Global Cancer Gene Therapy Revenue Share by Manufacturers
Table Global Market Cancer Gene Therapy Average Price (K USD/Unit) of Key Manufacturers (2013-2018)
Figure Global Market Cancer Gene Therapy Average Price (K USD/Unit) of Key Manufacturers in 2017
Table Manufacturers Cancer Gene Therapy Manufacturing Base Distribution and Sales Area
Table Manufacturers Cancer Gene Therapy Product Category
Figure Cancer Gene Therapy Market Share of Top 3 Manufacturers
Figure Cancer Gene Therapy Market Share of Top 5 Manufacturers
Table Global Cancer Gene Therapy Capacity (Units) by Region (2013-2018)
Figure Global Cancer Gene Therapy Capacity Market Share by Region (2013-2018)
Figure Global Cancer Gene Therapy Capacity Market Share by Region (2013-2018)
Figure 2017 Global Cancer Gene Therapy Capacity Market Share by Region
Table Global Cancer Gene Therapy Production by Region (2013-2018)
Figure Global Cancer Gene Therapy Production (Units) by Region (2013-2018)
Figure Global Cancer Gene Therapy Production Market Share by Region (2013-2018)
Figure 2017 Global Cancer Gene Therapy Production Market Share by Region
Table Global Cancer Gene Therapy Revenue (Million USD) by Region (2013-2018)
Table Global Cancer Gene Therapy Revenue Market Share by Region (2013-2018)
Figure Global Cancer Gene Therapy Revenue Market Share by Region (2013-2018)
Table 2017 Global Cancer Gene Therapy Revenue Market Share by Region
Figure Global Cancer Gene Therapy Capacity, Production (Units) and Growth Rate (2013-2018)
Table Global Cancer Gene Therapy Capacity, Production (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2013-2018)
Table North America Cancer Gene Therapy Capacity, Production (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2013-2018)
Table Europe Cancer Gene Therapy Capacity, Production (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2013-2018)
Table Asia-Pacific Cancer Gene Therapy Capacity, Production (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2013-2018)
Table South America Cancer Gene Therapy Capacity, Production (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2013-2018)
Table Middle East & Africa Cancer Gene Therapy Capacity, Production (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2013-2018)
Table Global Cancer Gene Therapy Consumption (Units) Market by Region (2013-2018)
Table Global Cancer Gene Therapy Consumption Market Share by Region (2013-2018)
Figure Global Cancer Gene Therapy Consumption Market Share by Region (2013-2018)
Figure 2017 Global Cancer Gene Therapy Consumption (Units) Market Share by Region
Table North America Cancer Gene Therapy Production, Consumption, Import & Export (Units) (2013-2018)
Table Europe Cancer Gene Therapy Production, Consumption, Import & Export (Units) (2013-2018)
Table Asia-Pacific Cancer Gene Therapy Production, Consumption, Import & Export (Units) (2013-2018)
Table South America Cancer Gene Therapy Production, Consumption, Import & Export (Units) (2013-2018)
Table Middle East & Africa Cancer Gene Therapy Production, Consumption, Import & Export (Units) (2013-2018)
Table Global Cancer Gene Therapy Production (Units) by Type (2013-2018)
Table Global Cancer Gene Therapy Production Share by Type (2013-2018)
Figure Production Market Share of Cancer Gene Therapy by Type (2013-2018)
Figure 2017 Production Market Share of Cancer Gene Therapy by Type
Table Global Cancer Gene Therapy Revenue (Million USD) by Type (2013-2018)
Table Global Cancer Gene Therapy Revenue Share by Type (2013-2018)
Figure Production Revenue Share of Cancer Gene Therapy by Type (2013-2018)
Figure 2017 Revenue Market Share of Cancer Gene Therapy by Type
Table Global Cancer Gene Therapy Price (K USD/Unit) by Type (2013-2018)
Figure Global Cancer Gene Therapy Production Growth by Type (2013-2018)
Table Global Cancer Gene Therapy Consumption (Units) by Application (2013-2018)
Table Global Cancer Gene Therapy Consumption Market Share by Application (2013-2018)
Figure Global Cancer Gene Therapy Consumption Market Share by Applications (2013-2018)
Figure Global Cancer Gene Therapy Consumption Market Share by Application in 2017
Table Global Cancer Gene Therapy Consumption Growth Rate by Application (2013-2018)
Figure Global Cancer Gene Therapy Consumption Growth Rate by Application (2013-2018)
Table Adaptimmune Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Adaptimmune Cancer Gene Therapy Capacity, Production (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2013-2018)
Figure Adaptimmune Cancer Gene Therapy Production Growth Rate (2013-2018)
Figure Adaptimmune Cancer Gene Therapy Production Market Share (2013-2018)
Figure Adaptimmune Cancer Gene Therapy Revenue Market Share (2013-2018)
Table GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlaxoSmithKline Cancer Gene Therapy Capacity, Production (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2013-2018)
Figure GlaxoSmithKline Cancer Gene Therapy Production Growth Rate (2013-2018)
Figure GlaxoSmithKline Cancer Gene Therapy Production Market Share (2013-2018)
Figure GlaxoSmithKline Cancer Gene Therapy Revenue Market Share (2013-2018)
Table Bluebird bio Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bluebird bio Cancer Gene Therapy Capacity, Production (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2013-2018)
Figure Bluebird bio Cancer Gene Therapy Production Growth Rate (2013-2018)
Figure Bluebird bio Cancer Gene Therapy Production Market Share (2013-2018)
Figure Bluebird bio Cancer Gene Therapy Revenue Market Share (2013-2018)
Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Cancer Gene Therapy Capacity, Production (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2013-2018)
Figure Merck Cancer Gene Therapy Production Growth Rate (2013-2018)
Figure Merck Cancer Gene Therapy Production Market Share (2013-2018)
Figure Merck Cancer Gene Therapy Revenue Market Share (2013-2018)
Table Celgene Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Celgene Cancer Gene Therapy Capacity, Production (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2013-2018)
Figure Celgene Cancer Gene Therapy Production Growth Rate (2013-2018)
Figure Celgene Cancer Gene Therapy Production Market Share (2013-2018)
Figure Celgene Cancer Gene Therapy Revenue Market Share (2013-2018)
Table Shanghai Sunway Biotech Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Shanghai Sunway Biotech Cancer Gene Therapy Capacity, Production (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2013-2018)
Figure Shanghai Sunway Biotech Cancer Gene Therapy Production Growth Rate (2013-2018)
Figure Shanghai Sunway Biotech Cancer Gene Therapy Production Market Share (2013-2018)
Figure Shanghai Sunway Biotech Cancer Gene Therapy Revenue Market Share (2013-2018)
Table BioCancell Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table BioCancell Cancer Gene Therapy Capacity, Production (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2013-2018)
Figure BioCancell Cancer Gene Therapy Production Growth Rate (2013-2018)
Figure BioCancell Cancer Gene Therapy Production Market Share (2013-2018)
Figure BioCancell Cancer Gene Therapy Revenue Market Share (2013-2018)
Table Shenzhen SiBiono GeneTech Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Shenzhen SiBiono GeneTech Cancer Gene Therapy Capacity, Production (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2013-2018)
Figure Shenzhen SiBiono GeneTech Cancer Gene Therapy Production Growth Rate (2013-2018)
Figure Shenzhen SiBiono GeneTech Cancer Gene Therapy Production Market Share (2013-2018)
Figure Shenzhen SiBiono GeneTech Cancer Gene Therapy Revenue Market Share (2013-2018)
Table SynerGene Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table SynerGene Therapeutics Cancer Gene Therapy Capacity, Production (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2013-2018)
Figure SynerGene Therapeutics Cancer Gene Therapy Production Growth Rate (2013-2018)
Figure SynerGene Therapeutics Cancer Gene Therapy Production Market Share (2013-2018)
Figure SynerGene Therapeutics Cancer Gene Therapy Revenue Market Share (2013-2018)
Table OncoGenex Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table OncoGenex Pharmaceuticals Cancer Gene Therapy Capacity, Production (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2013-2018)
Figure OncoGenex Pharmaceuticals Cancer Gene Therapy Production Growth Rate (2013-2018)
Figure OncoGenex Pharmaceuticals Cancer Gene Therapy Production Market Share (2013-2018)
Figure OncoGenex Pharmaceuticals Cancer Gene Therapy Revenue Market Share (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cancer Gene Therapy
Figure Manufacturing Process Analysis of Cancer Gene Therapy
Figure Cancer Gene Therapy Industrial Chain Analysis
Table Raw Materials Sources of Cancer Gene Therapy Major Manufacturers in 2017
Table Major Buyers of Cancer Gene Therapy
Table Distributors/Traders List
Figure Global Cancer Gene Therapy Capacity, Production (Units) and Growth Rate Forecast (2018-2025)
Figure Global Cancer Gene Therapy Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Cancer Gene Therapy Price (Million USD) and Trend Forecast (2018-2025)
Table Global Cancer Gene Therapy Production (Units) Forecast by Region (2018-2025)
Figure Global Cancer Gene Therapy Production Market Share Forecast by Region (2018-2025)
Table Global Cancer Gene Therapy Consumption (Units) Forecast by Region (2018-2025)
Figure Global Cancer Gene Therapy Consumption Market Share Forecast by Region (2018-2025)
Figure North America Cancer Gene Therapy Production (Units) and Growth Rate Forecast (2018-2025)
Figure North America Cancer Gene Therapy Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table North America Cancer Gene Therapy Production, Consumption, Export and Import (Units) Forecast (2018-2025)
Figure Europe Cancer Gene Therapy Production (Units) and Growth Rate Forecast (2018-2025)
Figure Europe Cancer Gene Therapy Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Europe Cancer Gene Therapy Production, Consumption, Export and Import (Units) Forecast (2018-2025)
Figure Asia-Pacific Cancer Gene Therapy Production (Units) and Growth Rate Forecast (2018-2025)
Figure Asia-Pacific Cancer Gene Therapy Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Asia-Pacific Cancer Gene Therapy Production, Consumption, Export and Import (Units) Forecast (2018-2025)
Figure South America Cancer Gene Therapy Production (Units) and Growth Rate Forecast (2018-2025)
Figure South America Cancer Gene Therapy Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table South America Cancer Gene Therapy Production, Consumption, Export and Import (Units) Forecast (2018-2025)
Figure Middle East & Africa Cancer Gene Therapy Production (Units) and Growth Rate Forecast (2018-2025)
Figure Middle East & Africa Cancer Gene Therapy Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Middle East & Africa Cancer Gene Therapy Production, Consumption, Export and Import (Units) Forecast (2018-2025)
Table Global Cancer Gene Therapy Production (Units) Forecast by Type (2018-2025)
Figure Global Cancer Gene Therapy Production (Units) Forecast by Type (2018-2025)
Table Global Cancer Gene Therapy Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Cancer Gene Therapy Revenue Market Share Forecast by Type (2018-2025)
Table Global Cancer Gene Therapy Price Forecast by Type (2018-2025)
Table Global Cancer Gene Therapy Consumption (Units) Forecast by Application (2018-2025)
Figure Global Cancer Gene Therapy Consumption (Units) Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
